A new generation XIAP inhibitor induces apoptosis of human myeloma cells and synergises with conventional and novel anti-myeloma therapeutics

被引:0
|
作者
Khong, Tiffany [1 ]
Spencer, Andrew [1 ]
机构
[1] Alfred Hosp, Myeloma Res Grp, Melbourne, Vic, Australia
关键词
D O I
10.1182/blood.V110.11.4787.4787
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
4787
引用
收藏
页码:270B / 270B
页数:1
相关论文
共 50 条
  • [1] Novel tubulin-polymerization inhibitor derived from thalidomide directly induces apoptosis in human multiple myeloma cells: Possible anti-myeloma mechanism of thalidomide
    Iguchi, Toyotaka
    Yachide-Noguch, Tomomi
    Hashimoto, Yuichi
    Nakazato, Sawako
    Sagawa, Morihiko
    Ikeda, Yasuo
    Kizaki, Masahiro
    INTERNATIONAL JOURNAL OF MOLECULAR MEDICINE, 2008, 21 (02) : 163 - 168
  • [2] A New IAP Inhibitor Induces Apoptosis of Myeloma Cells and Synergizes with Antimyeloma Therapeutics
    Khong, T. F.
    Spencer, A.
    CLINICAL LYMPHOMA & MYELOMA, 2009, 9 : S99 - S99
  • [3] Daratumumab Directly Induces Human Multiple Myeloma Cell Death and Acts Synergistically with Conventional and Novel Anti-Myeloma Drugs
    Kong, Sun-Young
    Li, Xian-Feng
    Nahar, Sabikun
    Song, Weihua
    de Weers, Michel
    Parren, Paul W. H. I.
    Richardson, Paul
    Munshi, Nikhil C.
    Anderson, Kenneth C.
    Tai, Yu-Tzu
    BLOOD, 2010, 116 (21) : 1241 - 1242
  • [4] The novel MEK Inhibitor GSK1120212b inhibits HMCL growth in vitro and synergises with a range of conventional and novel anti-myeloma therapies
    Khong, Tiffany T.
    Leow, Christopher
    Monaghan, Katherine
    Spencer, Andrew
    CANCER RESEARCH, 2012, 72
  • [5] Novel phosphatidylinositol 3-kinase inhibitor NVP-BKM120 induces apoptosis in myeloma cells and shows synergistic anti-myeloma activity with dexamethasone
    Yuhuan Zheng
    Jing Yang
    Jianfei Qian
    Liang Zhang
    Yong Lu
    Haiyan Li
    Heather Lin
    Yongsheng Lan
    Zhiqiang Liu
    Jin He
    Sungyoul Hong
    Sheeba Thomas
    Jatin Shah
    Veera Baladandayuthapani
    Larry W. Kwak
    Qing Yi
    Journal of Molecular Medicine, 2012, 90 : 695 - 706
  • [6] Novel phosphatidylinositol 3-kinase inhibitor NVP-BKM120 induces apoptosis in myeloma cells and shows synergistic anti-myeloma activity with dexamethasone
    Zheng, Yuhuan
    Yang, Jing
    Qian, Jianfei
    Zhang, Liang
    Lu, Yong
    Li, Haiyan
    Lin, Heather
    Lan, Yongsheng
    Liu, Zhiqiang
    He, Jin
    Hong, Sungyoul
    Thomas, Sheeba
    Shah, Jatin
    Baladandayuthapani, Veera
    Kwak, Larry W.
    Yi, Qing
    JOURNAL OF MOLECULAR MEDICINE-JMM, 2012, 90 (06): : 695 - 706
  • [7] A Novel Orally Bioavailable Heat Shock Protein 90 Inhibitor Induces Apoptosis and Synergises with Bortezomib in Human Multiple Myeloma
    Khong, Tiffany T.
    Yeh, Sung Lin
    Spencer, Andrew
    BLOOD, 2009, 114 (22) : 730 - 730
  • [8] Sulforaphane and PEITC Augment Activity of Conventional and Novel Anti-Myeloma Drugs
    Jakubikova, Jana
    Sedlak, Jan
    Klippel, Steffen
    Leiba, Merav
    Tai, Yu-Tzu
    Hideshima, Teru
    Podar, Klaus
    Chauhan, Dharminder
    Raje, Noopur
    Richardson, Paul G.
    Anderson, Kenneth C.
    Mitsiades, Constantine S.
    BLOOD, 2008, 112 (11) : 916 - 916
  • [9] Anti-Myeloma Activity of a Novel Glutaminase Inhibitor CB-839
    Sharma, Deepika
    Ravillah, Durgadevi
    Ray, Arghya
    Song, Yan
    Munshi, Nikhil C.
    Richardson, Paul G.
    Chauhan, Dharminder
    Anderson, Kenneth C.
    BLOOD, 2014, 124 (21)
  • [10] Berbamine, a novel nuclear factor κB inhibitor, inhibits growth and induces apoptosis in human myeloma cells
    Liang, Yun
    Xu, Rong-zhen
    Zhang, Lei
    Zhao, Xiao-ying
    ACTA PHARMACOLOGICA SINICA, 2009, 30 (12) : 1659 - 1665